A Study of Abemaciclib (LY2835219) in Combination With Other Anti-Cancer Treatments in Children and Young Adult Participants With Solid Tumors, Including Neuroblastoma
Eli Lilly and Company
Eli Lilly and Company
Milton S. Hershey Medical Center
Dana-Farber Cancer Institute
St. Jude Children's Research Hospital
Emory University
Washington University School of Medicine
National Cancer Institute (NCI)
National Cancer Institute (NCI)
National Institutes of Health Clinical Center (CC)